Show simple item record

dc.contributor.authorRakha, Emad A
dc.contributor.authorQuinn, Cecily
dc.contributor.authorMasannat, Yazan A
dc.contributor.authorLee, Andrew H. S.
dc.contributor.authorTan, Puay Hoon
dc.contributor.authorKarakatsanis, Andreas
dc.contributor.authorMatrai, Zoltan Tamas
dc.contributor.authorAl Shaibani, Salman Husain M
dc.contributor.authorGehani, Salahddin A
dc.contributor.authorShaaban, Abeer
dc.contributor.authorKhout, Hazem
dc.contributor.authorChagla, Leena
dc.contributor.authorCserni, Gábor
dc.contributor.authorVarga, Zsuzsanna
dc.contributor.authorYong, Wong Fuh
dc.contributor.authorMeattini, Icro
dc.contributor.authorKulka, Janina
dc.contributor.authorYang, Wentao
dc.contributor.authorTse, Gary M
dc.contributor.authorPinder, Sarah E
dc.contributor.authorFox, Stephen
dc.contributor.authorDixon, J Michael
dc.date.accessioned2024-11-04T16:32:15Z
dc.date.available2024-11-04T16:32:15Z
dc.date.issued2024-08-03
dc.identifier.citationRakha EA, Quinn C, Masannat YA, Lee AHS, Tan PH, Karakatsanis A, Matrai ZT, Al Shaibani SHM, Gehani SA, Shaaban A, Khout H, Chagla L, Cserni G, Varga Z, Yong WF, Meattini I, Kulka J, Yang W, Tse GM, Pinder SE, Fox S, Dixon JM. Revisiting surgical margins for invasive breast cancer patients treated with breast conservation therapy - Evidence for adopting a 1 mm negative width. Eur J Surg Oncol. 2024 Oct;50(10):108573. doi: 10.1016/j.ejso.2024.108573. Epub 2024 Aug 3.en_US
dc.identifier.issn0748-7983
dc.identifier.eissn1532-2157
dc.identifier.doi10.1016/j.ejso.2024.108573
dc.identifier.pmid39243583
dc.identifier.urihttp://hdl.handle.net/20.500.14200/6360
dc.description.abstractClinical trials have demonstrated conclusively the non-inferiority of breast-conserving surgery followed by breast radiation therapy (BCT) compared with mastectomy for the treatment of early-stage invasive breast cancer (BC). The definition of the required surgical margin to ensure adequate removal of the cancer by BCT to obtain an acceptable low local recurrence (LR) rate remains controversial. Meta-analyses published by Houssami et al. in 2010 and 2014 demonstrated significantly lower LR rates for patients with a negative margin compared with those with positive (ink on tumour) or close (defined as ≤1 mm or ≤2 mm) margins. Neither meta-analysis addressed whether 'no ink on tumour' was adequate to define a negative margin because of a lack of data. Nevertheless, in 2014, the Society of Surgical Oncology (SSO) and the American Society for Radiation Oncology (ASTRO) with advice from pathologists reviewed these data together and published guidelines recommending that a margin of 'no ink on tumour' was sufficient to define a clear margin in BCT. Subsequently, clinical practice has varied with some national and international bodies endorsing 'no ink on tumour', whilst others have recommended a ≥1 mm margin as acceptable margins for BCT. A more recent meta-analysis conducted by Bundred and colleagues in 2022 did have sufficient data to compare 'no ink on tumour' and 1 mm and concluded that 1 mm rather than 'no ink on tumour', should be used as a minimum negative margin, and recommended that international guidelines be revised. The current review presents a balanced assessment of the evidence relating margin width and local recurrence after BCT. This review concludes that guidelines should consider re-defining a negative margin as ≥1 mm rather than 'no ink on tumour' in the context of BCT, recognising there will be variation to tailor therapy for any individual patient situation to ensure optimal patient care.en_US
dc.language.isoenen_US
dc.publisherElsevieren_US
dc.relation.urlhttps://www.ejso.com/en_US
dc.rightsCopyright © 2024 The Author(s). Published by Elsevier Ltd.. All rights reserved.
dc.subjectOncology. Pathology.en_US
dc.subjectSurgeryen_US
dc.titleRevisiting surgical margins for invasive breast cancer patients treated with breast conservation therapy - Evidence for adopting a 1 mm negative widthen_US
dc.typeArticleen_US
dc.source.journaltitleEuropean Journal of Surgical Oncologyen_US
dc.source.volume50
dc.source.issue10
dc.source.beginpage108573
dc.source.endpage
dc.source.countryEngland
rioxxterms.versionNAen_US
dc.contributor.trustauthorShaaban, Abeer
dc.contributor.departmentHistopathologyen_US
dc.contributor.roleMedical and Dentalen_US
dc.contributor.affiliationUniversity of Nottingham; Nottingham University Hospitals NHS Trust; Hamad Medical Corporation; St. Vincent's University Hospital; University College, Dublin; Mid & South Essex NHS Trust; Princess Grace Hospital; Royal Square Medical Centre; Uppsala University; University of Birmingham; University Hospitals Birmingham NHS Foundation Trust; Mersey and West Lancashire Teaching Hospitals NHS Trust; Bács-Kiskun County Teaching Hospital; University of Szeged; University Hospital Zurich; Singapore General Hospital; University of Florence, Florence; Azienda Ospedaliero-Universitaria Careggi; Semmelweis University; Shanghai Cancer Center; The Chinese University of Hong Kong; Guy's and St Thomas Hospitals; King's College London; University of Melbourne; Edinburgh University; Western General Hospital Edinburghen_US
oa.grant.openaccessnaen_US


Files in this item

Thumbnail
Name:
Publisher version

This item appears in the following Collection(s)

Show simple item record